P73505 AF NFT

Isoleucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiabhp7njley2qfg4ii4wm634pquk6bwa5w7eictqnqztddywumuuy/metadata.json
IPFS of structure file: 
bafybeibazhs55qlcrqnasnaupabm733jtwxzckqwp6cyswfuktdcdacvie/AF-P73505-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x121FBE8cb498Fefb77e8499d91A1200302f3Fc6b
First NFT owner address (bech32): 
genesis1zg0mar95nrl0kalgfxwergfqqvp08lrtrvx6ws
Current NFT ID #449208 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
449208
Accession (UniProt):
P73505
Name::
Isoleucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
SYNECHOCYSTIS SP. (STRAIN PCC 6803 / KAZUSA)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P73505 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P73505|SYI_SYNY3 Isoleucine--tRNA ligase OS=Synechocystis sp. (strain PCC 6803 / Kazusa) OX=1111708 GN=ileS PE=3 SV=1 MTEAKSYKDTVNLPQTRFDMRANANKREPEIQQYWQEKGIYADLADNNPKDLFVLHDGPPYANGALHMGHALNKVLKDIINKYKLLQGHKVHYVPGWDCHGLPIELKVLQSLKSSERAELTPLTLRHKARDFALKAQQEQAVGFQRYGIWGDWKKPYLTLTPEYEAAQIGVFGAMALKGYIYRGLKPVHWSPSSRTALAEAELEYPEGHTSRSIYVSFPITQAGEKAAEILAPYIDDLAVAIWTTTPWTLPGNLAVALNPELTYAVVETESHIFHRSYLIVALDLVEKLSETFGVKLTVKVTLQGESLENTCYQHPLFDRVSPIVIGGDYVTTESGTGLVHTAPGHGQEDYVVGQRYGLPILSPVDAAGNLTEEAGKFAGLNVLNDANEAIINALQDQKVLLKEEAYEHKYPYDWRTKKPTIFRATEQWFASVEGFRDQALKAIKEVTWIPTQGENRITPMVGDRSDWCISRQRAWGVPIPVFYDEETSEPLLTEETINHVQQIIAEKGSDAWWELTVEELLPEAYRNNGRTYRKGEDTMDVWFDSGSSWAAVANAKNRPLKYPVDMYLEGSDQHRGWFQSSLLTSVAVNGIAPYKTVLTHGFVLDEKGHKMSKSLGNVVDPYQIINGGKNQKQEPAYGADVLRLWVASVDYANDVPIGQGILKQLVDIRNKIRNTARFLLGNLHDFNPETDAVAYEDLPELDRYMLHRMTEVFTEVTEAYESFQFFKFFQTVQNFCVVDLSNFYLDIAKDRLYISAPNAPRRRSCQTILQLALENLTKAIAPVLCHLAEDIWQFLPYEKPTESVFQSGWVNLDAQWQQPQLAQKWVSLRQLRDGINQLLEQARRDKVIGSSLEAKLIIVDPRTAESGTDEKQGENFVHWFYGWLENFNEPTFDPNDRKISLRNIFLTSQVEFIKSAEIEPSFTYEETVVINLERHDNNIRTKPIKIIVTKADGHKCERCWNYSTQVGSFSDDPTICERCNEALQGNF